Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15841046 | 0.85 | — | — | |
| SCHEMBL16175948 | 0.84 | ALDH1A1 (0.40) | HSD17B10KDM4EHPGDTP53RAB9A | |
| SCHEMBL15829529 | 0.83 | MAPT (0.44) | HSD17B10KDM4EHPGDTP53RAB9A | |
| SCHEMBL15841049 | 0.80 | CYP1A2 (0.32) | HSD17B10KDM4EALDH1A1 | |
| SCHEMBL15841047 | 0.80 | USP2 (0.30) | — | |
| SCHEMBL15841025 | 0.79 | ALDH1A1 (0.40) | HSD17B10KDM4EPOLBTP53RAB9A | |
| SCHEMBL15841037 | 0.79 | ALDH1A1 (0.32) | HSD17B10TP53RAB9AALDH1A1LMNA | |
| SCHEMBL15841097 | 0.79 | — | — | |
| SCHEMBL15841085 | 0.79 | — | — | |
| SCHEMBL15841084 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935293-B1 | IRIDIUM COMPLEXES AND THEIR USE IN ELECTRONIC DEVICES, ESPECIALLY ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-08-21 | — | — | EP | disclosed |
| US-20150318498-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20150318498-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| WO-2014094962-A2 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150318498-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | HSD17B10 2888/4885KDM4E 3816/4885HPGD 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.